Antimicrobial Drugs: Mechanisms, Targets, and Clinical Applications

Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are agents used to kill or inhibit the growth of microorganisms, including bacteria, fungi, protozoa, helminths, and viruses. These drugs are essential in the treatment of infectious diseases and are classified based on their spectrum of activity and mechanism of action.

• Antibiotics: Naturally produced antibacterial agents, often derived from molds or bacteria (e.g., Penicillium produces penicillin).

• Antibacterial: Drugs that target bacteria specifically.

• Antifungal, Antiprotozoan, Antihelminthic, Antiviral: Drugs targeting fungi, protozoa, helminths, and viruses, respectively.

• Antimicrobial: General term for any drug that kills or inhibits microbes.

Key Terms:

• Bactericidal: Kills bacteria (e.g., penicillin).

• Bacteriostatic: Inhibits bacterial growth (e.g., tetracycline).

• Selective toxicity: The drug harms the microbe more than the host.

Mechanisms of Antimicrobial Action

Common Drug Targets

Antimicrobial drugs act by targeting structures or processes unique to microbes. The main targets include:

• Cell wall synthesis

• Cell membrane integrity

• Protein synthesis (ribosomes)

• Nucleic acid synthesis (DNA/RNA)

• Metabolic pathways (e.g., folic acid synthesis)

• Mycolic acid synthesis (in mycobacteria)

1. Inhibition of Cell Wall Synthesis

Many bacteria have a cell wall composed of peptidoglycan, which is absent in human cells. Drugs targeting cell wall synthesis are often bactericidal.

• β-lactams: (e.g., penicillins, cephalosporins, monobactams, carbapenems) bind to penicillin-binding proteins (PBPs), blocking peptidoglycan cross-linking.

• Glycopeptides: (e.g., vancomycin) bind to peptidoglycan subunits, preventing their incorporation into the cell wall.

• Bacitracin: Inhibits the transport of peptidoglycan subunits across the cell membrane.

Example: Penicillin inhibits peptidoglycan synthesis, leading to bacterial cell lysis.

2. Disruption of Cell Membrane Integrity

Drugs targeting the cell membrane cause leakage of cellular contents, leading to cell death. These are usually bactericidal.

• Polymyxins: (e.g., polymyxin B, colistin) disrupt the outer membrane of Gram-negative bacteria.

• Lipopeptides: (e.g., daptomycin) disrupt the cell membrane of Gram-positive bacteria.

Note: These drugs are selective based on the presence of specific membrane structures in bacteria.

3. Inhibition of Nucleic Acid Synthesis

These drugs interfere with DNA replication or RNA transcription, leading to cell death (bactericidal).

• Fluoroquinolones: Inhibit DNA gyrase (topoisomerase), blocking DNA replication.

• Rifamycins: Block bacterial RNA polymerase, inhibiting transcription.

• Metronidazole: Binds DNA and is only active in anaerobic cells.

Example: Ciprofloxacin (a fluoroquinolone) is used to treat urinary tract infections by inhibiting DNA gyrase.

4. Inhibition of Protein Synthesis

Bacterial ribosomes (70S) differ from eukaryotic ribosomes (80S), allowing selective targeting.

• 30S subunit inhibitors:

  • Aminoglycosides: Impair proofreading, causing faulty proteins (bactericidal).

  • Tetracyclines: Block tRNA binding, inhibiting protein synthesis (bacteriostatic).

• 50S subunit inhibitors:

  • Macrolides, Lincosamides, Chloramphenicol, Oxazolidinones: Prevent peptide bond formation (bacteriostatic).

Example: Azithromycin (a macrolide) is used for respiratory infections.

5. Inhibition of Metabolic Pathways

Some drugs block essential metabolic pathways unique to microbes, such as folic acid synthesis.

• Sulfonamides and Trimethoprim: Inhibit enzymes in the folic acid pathway. Used together, they are bactericidal; alone, bacteriostatic.

Example: Combination therapy (co-trimoxazole) is used for urinary tract infections.

6. Inhibition of Mycolic Acid Synthesis

Mycolic acids are unique to Mycobacterium species (e.g., tuberculosis).

• Isoniazid: Inhibits mycolic acid synthesis, weakening the cell wall (bactericidal in dividing cells).

Spectrum of Activity

Broad vs. Narrow Spectrum

• Broad-spectrum: Effective against a wide range of bacteria (both Gram-positive and Gram-negative).

• Narrow-spectrum: Effective against a limited group, usually only Gram-positive or Gram-negative bacteria.

Antifungal, Antiprotozoan, Antihelminthic, and Antiviral Drugs

Antifungal Drugs

Fungal cells have unique components such as ergosterol in their membranes and β-glucans and chitin in their cell walls.

• Targets: Ergosterol (cell membrane), β-glucans, and chitin (cell wall).

Antiviral Drugs

Antiviral drugs target specific steps in the viral life cycle.

• Herpes: Acyclovir is activated by viral enzymes and blocks DNA synthesis in infected cells.

• HIV: Multiple targets including fusion inhibitors, reverse transcriptase inhibitors, integrase inhibitors, and protease inhibitors.

• COVID-19 (SARS-CoV-2): Drugs target viral entry, protease, and RNA synthesis (e.g., monoclonal antibodies, nirmatrelvir/ritonavir [Paxlovid], remdesivir, molnupiravir).

Routes of Administration and Pharmacokinetics

Drug Administration Routes

• Intravenous (IV): Directly into the bloodstream for rapid effect.

• Oral: Convenient, but absorption may vary.

• Topical: Applied to skin or mucous membranes.

• Intramuscular (IM): Injected into muscle tissue.

Pharmacokinetics

Describes how the body absorbs, distributes, metabolizes, and excretes drugs.

• Tissue distribution: How well the drug reaches the site of infection.

• Metabolism: How quickly the drug is broken down (e.g., penicillin V is excreted quickly, requiring frequent dosing; azithromycin is excreted slowly, allowing once-daily dosing).

• Excretion: Removal of the drug from the body, primarily via the kidneys.

Summary Table: Major Antimicrobial Drug Classes and Targets

Drug Class	Main Target	Example(s)	Spectrum
β-lactams	Cell wall (peptidoglycan synthesis)	Penicillins, Cephalosporins	Broad/Narrow
Glycopeptides	Cell wall (peptidoglycan subunits)	Vancomycin	Narrow (Gram+)
Polymyxins	Cell membrane (outer membrane)	Polymyxin B, Colistin	Narrow (Gram-)
Lipopeptides	Cell membrane	Daptomycin	Narrow (Gram+)
Fluoroquinolones	DNA synthesis (DNA gyrase)	Ciprofloxacin	Broad
Rifamycins	RNA synthesis (RNA polymerase)	Rifampin	Broad
Aminoglycosides	Protein synthesis (30S subunit)	Gentamicin	Broad
Tetracyclines	Protein synthesis (30S subunit)	Tetracycline	Broad
Macrolides	Protein synthesis (50S subunit)	Azithromycin	Broad
Sulfonamides/Trimethoprim	Folic acid synthesis	Sulfamethoxazole/Trimethoprim	Broad
Isoniazid	Mycolic acid synthesis	Isoniazid	Narrow (Mycobacteria)

Key Equations

• Minimum Inhibitory Concentration (MIC): The lowest concentration of a drug that inhibits visible growth of a microorganism.

• Therapeutic Index (TI): Ratio of toxic dose to therapeutic dose: $TI = \frac{\text{Toxic Dose}}{\text{Therapeutic Dose}}$

Summary

• Antimicrobial drugs are classified by their targets and mechanisms of action.

• Selective toxicity is crucial for effective and safe therapy.

• Understanding drug spectrum, pharmacokinetics, and administration routes is essential for clinical use.

Additional info: Some explanations and examples were expanded for clarity and completeness based on standard microbiology textbooks.